相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity
Antje Arnold et al.
NEURO-ONCOLOGY (2020)
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study
Nicole J. Ullrich et al.
NEURO-ONCOLOGY (2020)
SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma
Astrid K. Gnekow et al.
KLINISCHE PADIATRIE (2019)
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
Jason Fangusaro et al.
LANCET ONCOLOGY (2019)
Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature Review
Giuseppe Petruzzellis et al.
FRONTIERS IN GENETICS (2019)
Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma
Danielle S. Bitterman et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Late Effects After Radiotherapy for Childhood Low-grade Glioma
Noelle L. Williams et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yibing Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yibing Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling
G. Catanzaro et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
WHO 2016 Classification of gliomas
P. Wesseling et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Role of mTOR Signaling in Tumor Microenvironment: An Overview
Fabiana Conciatori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Trametinib for progressive pediatric low-grade gliomas
Maria Kondyli et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
FBXW7: a critical tumor suppressor of human cancers
Chien-Hung Yeh et al.
MOLECULAR CANCER (2018)
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee et al.
NEURO-ONCOLOGY (2017)
Probing the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Pathway in Gliomas: A Phase 2 Study of Everolimus for Recurrent Adult Low-Grade Gliomas
Michael Wahl et al.
CANCER (2017)
Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group
Joann L. Ater et al.
CANCER (2016)
Phase II Weekly Vinblastine for Chemotherapy-Naive Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
Alvaro Lassaletta et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study
Murali Chintagumpala et al.
NEURO-ONCOLOGY (2015)
The mTOR signaling pathway as a treatment target for intracranial neoplasms
Doreen Pachow et al.
NEURO-ONCOLOGY (2015)
The role of surgery in optic pathway/hypothalamic gliomas in children Clinical article
John Goodden et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2014)
FINAL RESULTS OF A PROSPECTIVE MULTI-INSTITUTIONAL PHASE II STUDY OF EVEROLIMUS (RAD001), AN MTOR INHIBITOR, IN PEDIATRIC PATIENTS WITH RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA. A POETIC CONSORTIUM TRIAL
Mark W. Kieran et al.
NEURO-ONCOLOGY (2014)
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
Matthias A. Karajannis et al.
NEURO-ONCOLOGY (2014)
Long-term outcome of centrally located low-grade glioma in children
Keita Terashima et al.
CANCER (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target
Marianne Huett-Cabezas et al.
NEURO-ONCOLOGY (2013)
Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas
Eugene I. Hwang et al.
PEDIATRIC BLOOD & CANCER (2013)
Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
Angela J. Sievert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tumor suppressor functions of FBW7 in cancer development and progression
Zhiwei Wang et al.
FEBS LETTERS (2012)
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
Joann L. Ater et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology
Astrid K. Gnekow et al.
NEURO-ONCOLOGY (2012)
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
Sean M. McBride et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.
Darcy A. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pediatric Low-Grade Gliomas
Angela J. Sievert et al.
JOURNAL OF CHILD NEUROLOGY (2009)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phase I study of everolimus in pediatric patients with refractory solid tumors
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Bhaswati Pandit et al.
NATURE GENETICS (2007)
分享论文
